Nanodynamic Therapies against Cancer and Microbial Infections

Dear Colleagues,

Nanodynamic therapies are emerging as one of the most highly effective therapeutic modalities for the treatment of cancers and microbial infections, particularly nanosensitizers that are capable of producing active free radicals/reactive oxygen species (ROS) upon stimuli to induce cell death. Nanodynamic therapies such as photodynamic therapy (PDT), chemodynamic therapy (CDT), sonodynamic therapy (SDT), thermodynamic therapy (TDT), radiodynamic therapy (RDT), electrodynamic therapy (EDT), piezoelectric dynamic therapy (PZDT), and pyroelectric dynamic therapy (PEDT) have been successfully introduced in recent years. In principle, the generation of ROS originates from two types of energy inputs such as exogenous energy activators (e.g., light, ultrasound (US), magnetic field, electricity, and ionizing irradiation) and endogenous chemical energy sources, including hydrogen peroxide (H₂O₂). Based on the high specificity of the external and internal triggers, these emerging dynamic therapies have achieved fast development and implementation very recently.

We invite all researchers to submit their findings related to nanomaterials for use in nanodynamic therapies against cancer and microbial infections.

This Special Issue, entitled “Nanodynamic Therapies against Cancer and Microbial Infections”, aims to collect many original research articles and reviews concerning the synthesis of various types of nanomaterials, their characterization,  in vitro and in vivo cancer and microbial infection studies, and clinical trials in pharmaceutical fields. In addition, research work that aims to increase our knowledge about the synthesis of various nanomaterials, their characterization, and the treatment of cancer and microbial infections are welcome.

We look forward to receiving your contributions.

Prof. Dr. Panchanathan Manivasagan
Prof. Dr. Eue-Soon Jang
Prof. Dr. Thambi Thavasyappan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.